Verónica Bryant
Impact in
-
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 3
- Surgery 2
- Case Reports on Hematomas 1
- Co-authors
- Francisco J. de Abajo (4 shared papers)Belén Oliva (3 shared papers)Miguel Gil (4 shared papers)Luis A. García‐Rodríguez (3 shared papers)M. Maciá (1 shared paper)Antonio Rodríguez (1 shared paper)Dolores Montero (1 shared paper)Consuelo Huerta (2 shared papers)
- Journals
- Pharmacoepidemiology and Drug Safety (3 papers)Heart (1 paper)European Journal of Clinical Pharmacology (1 paper)MMWR Morbidity and Mortality Weekly Report (1 paper)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- SpainJapanUnited States
In The Last Decade
Verónica Bryant
7 papers receiving 288 citations
Peers
Comparison fields: 5 of 68
- Nephrology 36
- Toxicology 16
- Endocrinology, Diabetes and Metabolism 59
- Pharmacology 49
- Geriatrics and Gerontology 11
Countries citing papers authored by Verónica Bryant
This map shows the geographic impact of Verónica Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verónica Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verónica Bryant more than expected).
Fields of papers citing papers by Verónica Bryant
This network shows the impact of papers produced by Verónica Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verónica Bryant. The network helps show where Verónica Bryant may publish in the future.
Co-authors
The 13 scholars most cited alongside Verónica Bryant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 93 | |
| 2 | 2012 | 59 | |
| 3 | 2014 | 49 | |
| 4 | 2015 | 42 | |
| 5 | 2020 | 40 | |
| 6 | 2015 | 6 | |
| 7 | 2024 | 2 | |
| 8 | 2021 | 0 |
About Verónica Bryant
Verónica Bryant is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Pharmacology, Geriatrics and Gerontology and Nephrology, having authored 8 papers that have together received 291 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Inflammatory mediators and NSAID effects (2 papers), Pharmacovigilance and Adverse Drug Reactions (1 paper), Meningioma and schwannoma management (1 paper), Pituitary Gland Disorders and Treatments (1 paper), Heavy Metal Exposure and Toxicity (1 paper) and Case Reports on Hematomas (1 paper). The work is most often cited by research in Nephrology (36 citations), Toxicology (16 citations), Endocrinology, Diabetes and Metabolism (59 citations), Pharmacology (49 citations) and Geriatrics and Gerontology (11 citations). Verónica Bryant has collaborated with scholars based in Spain, Japan and United States. Frequent co-authors include Francisco J. de Abajo, Belén Oliva, Miguel Gil, Luis A. García‐Rodríguez, M. Maciá, Antonio Rodríguez, Dolores Montero, Consuelo Huerta, Elisa Martín‐Merino and María Victoria Castell. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, Heart, European Journal of Clinical Pharmacology, MMWR Morbidity and Mortality Weekly Report and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.